3 models fit Qualitas Controladora and they disagree: 1 of 3 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Bronze57
Valued as an insurer: Residual income, P/E comparison, and Dividend discount.
ACCE opinionQualitas Controladora (Q.MX)
Fair value (3 models)
MXN 119
ACCE price target
MXN 195
Rating
Overvalued
Horizon
12 months
Fair value published on 23 Oct 2026, 11:04 CEST; previously MXN 117 since 21 Oct 2026, 11:06 CEST.
ACCE price target published on 24 Oct 2026, 03:20 CEST; previously MXN 179 since 17 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 14:06 CEST.
Price used: MXN 190 at the close on 23 Oct 2026, 23:00 CEST.
Models: P/E comparison, Dividend discount, and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
60.1% above
-37.5% to fair value
ACCE score
56
out of 100
P/E
17.8x
forward 8.8x
1-year return
+15.2%
Dividend yield
0.00%
Qualitas Controladora in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Qualitas Controladora writes auto insurance in Mexico through its Qualitas Compañía de Seguros unit, along with property and other P&C lines, and sells mostly through its own agents and a broker channel. Its advantage is distribution density and claims handling in a market where a large share of vehicles are uninsured, so premium growth is tied to a structural penetration gap rather than to the cycle. Revenue grew 3.7% over the latest period, which is modest, and the stock trades at 16.8 times trailing earnings but 12.2 times forward, implying the market expects earnings to recover. Return on equity of 18.3% is the number that matters most here, since it is well above what most Mexican insurers earn and it has to hold as the company absorbs claims inflation. The score of 56/100 and the absence of any index membership suggest the market has not yet priced the margin story, so the question for the team is whether the forward earnings step-up is credible given a 10.7% operating margin.